Target Biopsy and Core Number in Prostate Biopsy.

Wei-Wei Shen,Li-Gang Cui,Yan Sun

DOI: https://doi.org/10.1016/j.ultrasmedbio.2020.11.003

IF: 3.694

2020-01-01

Ultrasound in Medicine & Biology

Abstract:The ideal method to diagnose prostate cancer (PCa) should be minimally invasive with few complications, and must provide a higher sensitivity for diagnosing clinically significant PCa than clinically insignificant PCa ( Kasivisvanathan et al., 2018 Kasivisvanathan V Rannikko AS Borghi M Panebianco V Mynderse LA Vaarala MH Briganti A Budaus L Hellawell G Hindley RG Roobol MJ Eggener S Ghei M Villers A Bladou F Villeirs GM Virdi J Boxler S Robert G Singh PB Venderink W Hadaschik BA Ruffion A Hu JC Margolis D Crouzet S Klotz L Taneja SS Pinto P Gill I Allen C Giganti F Freeman A Morris S Punwani S Williams NR Brew-Graves C Deeks J Takwoingi Y Emberton M Moore CM MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018; 19: 1767-1777 Crossref Scopus (1012) Google Scholar ). Previous studies have shown that targeted biopsy (TBx) and 12-core system biopsy (12-SBx) are often performed simultaneously to avoid missing a diagnosis of clinically significant PCa; consequently, more biopsy cores are obtained when performing multiparametric magnetic resonance imaging (MRI)/Transrectal Ultrasound (TRUS) fusion biopsy ( Ahmed et al., 2017 Ahmed HU El-Shater BA Brown LC Gabe R Kaplan R Parmar MK Collaco-Moraes Y Ward K Hindley RG Freeman A Kirkham AP Oldroyd R Parker C Emberton M Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study. Lancet. 2017; 389: 815-822 Abstract Full Text Full Text PDF PubMed Scopus (1279) Google Scholar ). The aim of our research was to develop an alternative sampling scheme that utilizes fewer biopsy cores while maintaining a diagnostic efficiency for PCa equivalent to that of TBx + 12-SBx.